On September 1, Cynthia Herrick, MD, FACP and collaborators had their work titled “Adverse Pregnancy Outcomes and Postpartum Care as a Pathway to Future Health,” published in “Clinical Obstetrics and Gynecology.” Adverse pregnancy outcomes (APOs) are said to collectively represent “the leading causes of maternal and neonatal morbidity and mortality.” When APOs occur, disease trajectory […]
On September 13, Alexis M. McKee, MD, CDCES had an article published on “Endocrine Web,” titled “What Is Insulin Glargine and What Are Its Side Effects?” Insulin glargine is a long-acting insulin, sometimes referred to as basal. When glargine was discovered, it was a game-changer in diabetes management because it allowed those with diabetes to stop using […]
On August 30, Fumihiko Urano, MD, PhD and colleagues had their research titled “Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome,” published in “Proceedings of the National Academy of Sciences of the United States of America.” Albuminuria is a symptom of glomerular disease and a leading cause of […]
On November 10, our annual Diabetes Day Symposium took place at the Eric P. Newman Education Center. The event hosted guest speaker Debbie Thurmond, PhD, of City of Hope Beckman Research Institute, presenting “Reversing Type 2 Diabetes: Getting the Band Back Together.” Also taking place during the symposium, fifty-eight poster presenters showcased their work to […]
On June 15, Clay F. Semenkovich, MD and collaborators had their research titled “Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments,” published in “Frontiers in Cardiovascular Medicine.” “Peripheral atherosclerosis that accumulates in the extracranial carotid and lower extremity arteries can lead to significant morbidity and mortality. However, atherosclerotic disease progression is […]
In August, Johnathon Seth Parham, MD and Anne Carol Goldberg, MD, FACP had their review titled “Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know,” published in “Current Atherosclerosis Reports.” The review looks at two new lipid-lowering treatment medications, bempedoic acid and inclisiran. “Bempedoic acid inhibits adenosine citrate lyase, decreasing […]
On July 24, Is-haq Malik, MD and Max Petersen, MD, PhD had their research titled “Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor poly-agonists: a new era in obesity pharmacotherapy,” published in “Obesity Society.” The purpose of the study was to assess newly approved medications for treating obesity. “Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, […]
Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug. Biosense is a non-invasive option to capillary […]
On September 28, Paulina Cruz Bravo, MD and collaborators had their research titled “Developing Priorities to Alleviate the Long-Term Impact of the COVID-19 Pandemic on Women Engaged in Diabetes Research, Education, and Care: A Concept Mapping Study,” published by the American Diabetes Association. The study used multiple methods “to develop priorities through stakeholder engagement to alleviate […]